Page last updated: 2024-09-04

cyc 202 and butein

cyc 202 has been researched along with butein in 1 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(butein)
Trials
(butein)
Recent Studies (post-2010) (butein)
97973931710110

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)butein (IC50)
Epidermal growth factor receptorHomo sapiens (human)8
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)0.0046
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.73
17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)7.3
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)6.4
Beta-secretase 1Homo sapiens (human)2.37
Xanthine dehydrogenase/oxidaseBos taurus (cattle)1.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brongel, K; Czarna, A; Holak, TA; Kowalska, K; Orth, M; Popowicz, GM; Rothweiler, U; Stemmann, O; Weber, L1

Other Studies

1 other study(ies) available for cyc 202 and butein

ArticleYear
NMR screening for lead compounds using tryptophan-mutated proteins.
    Journal of medicinal chemistry, 2008, Aug-28, Volume: 51, Issue:16

    Topics: Cyclin-Dependent Kinase 2; Drug Evaluation, Preclinical; Humans; Lead; Ligands; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Point Mutation; Protein Interaction Mapping; Proteins; Proto-Oncogene Proteins c-mdm2; Structure-Activity Relationship; Tryptophan; Tumor Suppressor Protein p53

2008